Arvinas (ARVN) EBT (QoQ) (2017 - 2026)
Arvinas (ARVN) EBT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Arvinas | 529.28 Mn | -85.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.43% |
| Dec 31, 2025 | -93.10% |
| Sep 30, 2025 | 43.41% |
| Jun 30, 2025 | -174.01% |
| Mar 31, 2025 | 282.64% |
| Dec 31, 2024 | 6.38% |
| Sep 30, 2024 | -38.86% |
| Jun 30, 2024 | 49.49% |
| Mar 31, 2024 | 54.77% |
| Dec 31, 2023 | -139.75% |
| Sep 30, 2023 | 2.59% |
| Jun 30, 2023 | 19.21% |
| Mar 31, 2023 | -17.17% |
| Dec 31, 2022 | -13.42% |
| Sep 30, 2022 | 4.68% |
| Jun 30, 2022 | -13.25% |
| Mar 31, 2022 | -22.78% |
| Dec 31, 2021 | 1.50% |
| Sep 30, 2021 | 6.96% |
| Jun 30, 2021 | -22.68% |